SCHEMBL24104651

SCHEMBL24104651

CC(=O)Nc1ccc(Nc2nccn3c(-c4ccc(Cl)cc4)cnc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TTK P33981 10/20 0.53
▸ MAPKAPK5 Q8IW41 2/20 0.48
▸ AURKA O14965 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ PTK6 Q13882 1/20 0.45
▸ TP53 P04637 1/20 0.44
▸ POLB P06746 1/20 0.42
▸ ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24105022 0.87 TTK (0.52) TTKMAPKAPK5AURKAMEN1ALDH1A1
SCHEMBL24104803 0.87 TTK (0.46) TTKMAPKAPK5AURKAPTK6
SCHEMBL30168183 0.87 TTK (0.46) TTKMAPKAPK5AURKAPTK6
SCHEMBL25174057 0.85 TTK (0.52) TTKMAPKAPK5AURKAMEN1MAPT
SCHEMBL5411354 0.85 TTK (0.61) TTKMAPKAPK5HTTSMN1; SMN2
SCHEMBL24105218 0.84 PTK6 (0.47) TTKMAPKAPK5AURKAALDH1A1PTK6
SCHEMBL25447269 0.84 TTK (0.51) TTKMAPKAPK5AURKAPTK6
SCHEMBL22160262 0.83 TTK (0.49) TTKMAPKAPK5AURKAPTK6
SCHEMBL24104665 0.82 MAPT (0.56) TTKMAPKAPK5AURKAMAPTPTK6
SCHEMBL24104653 0.82 TTK (0.50) TTKMAPKAPK5AURKAKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230141403-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-05-11 — — US disclosed
US-20230141403-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-05-11 — — US disclosed
CN-115667264-A Novel imidazo-pyrazine derivatives 豪夫迈·罗氏有限公司 2023-01-31 — — CN disclosed
WO-2021249893-A1 NOVEL IMIDAZO-PYRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2021-12-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230141403-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES XDH, MYD88, IKZF3 TTK 4157/4885MAPKAPK5 771/4885AURKA 2897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback